ACLX · As filed with the SEC
Arcellx income statement, by quarter
The statement as Arcellx presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS · USD, except per-share amounts
| USD, except per-share amounts | Q4 2025 3 months ended Dec 31, 2025 | Q3 2025 3 months ended Sep 30, 2025 | Q2 2025 3 months ended Jun 30, 2025 | Q1 2025 3 months ended Mar 31, 2025 |
|---|---|---|---|---|
| Collaboration revenue from related party | — | 4,949,000 | 7,554,000 | 8,129,000 |
| Operating expenses: | ||||
| Research and development | — | 35,088,000 | 37,627,000 | 50,801,000 |
| General and administrative | — | 31,637,000 | 28,653,000 | 26,226,000 |
| Total operating expenses | — | 66,725,000 | 66,280,000 | 77,027,000 |
| Loss from operations | — | (61,776,000) | (58,726,000) | (68,898,000) |
| Other income (expense): | ||||
| Interest and other income (expense) | — | 5,995,000 | 5,984,000 | 6,640,000 |
| Interest expense | — | 0 | 0 | (12,000) |
| Total other income, net | — | 5,995,000 | 5,984,000 | 6,628,000 |
| Loss before income taxes | — | (55,781,000) | (52,742,000) | (62,270,000) |
| Income tax expense | — | 0 | (29,000) | 0 |
| Net loss | — | (55,781,000) | (52,771,000) | (62,270,000) |
| Other comprehensive loss: | ||||
| Unrealized gain (loss) on marketable securities | — | 303,000 | (246,000) | (199,000) |
| Comprehensive loss | — | (55,478,000) | (53,017,000) | (62,469,000) |
| Net loss per share attributable to common stockholders - basic | — | (0.99) | (0.94) | (1.13) |
| Net loss per share attributable to common stockholders - diluted | — | (0.99) | (0.94) | (1.13) |
| Weighted-average common shares outstanding - basic | — | 56,587,167 | 56,221,331 | 55,256,464 |
| Weighted-average common shares outstanding - diluted | — | 56,587,167 | 56,221,331 | 55,256,464 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.